IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
This study has been completed.
Sponsor:
Stanford University
Collaborator:
Bayer
Information provided by (Responsible Party):
Sandy Srinivas, Stanford University
ClinicalTrials.gov Identifier:
NCT00477087
First received: May 18, 2007
Last updated: July 3, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2010 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |